Neuroreader®
Brainreader
Information source:
Vendor
Last updated: October 7, 2024 |
General Information
General | |
---|---|
Product name | Neuroreader® |
Company | Brainreader |
Subspeciality | Neuro |
Modality | MR |
Disease targeted | Neurodegenerative disorders |
Key-features | Brain region quantification, comparison to a normative database |
Suggested use | Diagnostic aid |
Technical Specifications
Data characteristics | |
---|---|
Population | People with neurogenerative disorders |
Input | 3D, T1, weighted MPRAGE, 1 mm thickness (max 1.2 mm), without contrast (or procontrast) |
Input format | DICOM |
Output | Segmentation overlay, report with volume metrics |
Output format | DICOM, secondary capture |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Cloud-based |
Trigger for analysis | On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 1 - 10 minutes |
Regulatory
Certification | |
---|---|
CE |
Certified,
Class I
, MDD
|
FDA | 510(k) cleared , Class II |
Intended Use Statements | |
Intended use (according to CE) |
Market
Market presence | |
---|---|
On market since | 02-2015 |
Distribution channels | Blackford |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use |
Based on |
Evidence
Evidence | |
---|---|
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |